Publikationen in Zusammenarbeit mit Forschern von Tokyo Medical University Hospital (1)

2023

  1. Pembrolizumab plus chemotherapy in Japanese patients with triple-negative breast cancer: Results from KEYNOTE-355

    Cancer Medicine, Vol. 12, Núm. 9, pp. 10280-10293